Atia Vision, Inc., a Campbell, CA-based medical device company formed by Shifamed LLC, held the first close of a $42M Series E financing.
The round was led by Cormorant Asset Management, with participation by The Capital Partnership (TCP), PA MedTech VC Fund, AMED Ventures and Shifamed angel investors.
The company intends to use the funds to expand its clinical program, scale its manufacturing capabilities, and expand the team.
Led by Mariam Maghribi, President and CEO, Atia Vision is committed to improving patient outcomes through the development of a modular presbyopia-correcting intraocular lens (IOL). Its modular intraocular lens technology aims to address the limitations of current solutions. Implanted using conventional cataract techniques, the innovation features a shape-changing, fluid-filled base and is designed to have an exchangeable fixed power front optic, allowing physicians to select the appropriate lens to meet each patient’s target refraction. The dual lens system is responsive to the natural accommodative mechanism and aims to provide dynamic power response for clear vision from far to near.
FinSMEs
02/08/2022